• DOI:10.1007/s00213-004-1957-9
Corpus ID: 24842052

Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial

@article{Stein2004EfficacyOL,
  title={Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial},
  author={M. Stein and M. Pollack and A. Bystritsky and J. Kelsey and R. Mangano},
  journal={Psychopharmacology},
  year={2004},
  volume={177},
  pages={280-288}
}

M. Stein, M. Pollack, +2 authors R. Mangano

Published 2004

Medicine

Psychopharmacology

RationaleThere is a need for new pharmacological treatments for generalized social anxiety disorder (GSAD), which is a common, often disabling condition.ObjectiveTo compare the efficacy and safety over 6 months duration of two dose ranges of venlafaxine extended-release (ER) with placebo in patients with GSAD.MethodTwenty-eight-week, double-blind, multi-center study in 386 adult outpatients with DSM-IV GSAD. Patients were randomized to placebo, venlafaxine ER fixed low dose (75 mg/day), or… CONTINUE READING

View on Springer

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed